ObsEva Files Year End 2022 Financial Statements

Rhea-AI Summary

ObsEva has released its U.S. Annual Report on Form 10-K for the fiscal year 2022, disclosing key financial results as of year-end 2022. The report can be accessed on its website. The company, focusing on women's reproductive health and pregnancy, is traded on the SIX Swiss Exchange under the ticker OBSN and on the OTC Pink Market as OBSVF. Additionally, ObsEva plans to publish its Swiss Annual Report to Shareholders, including IFRS results, in the week of April 24, 2023.

Positive

• Released U.S. Annual Report on Form 10-K for year-end 2022
• Continues focus on women's reproductive health and pregnancy

Negative

• None.

ObsEva Files Year End 2022 Financial Statements

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange

GENEVA, Switzerland – March 31, 2023 – ObsEva SA (SIX: OBSN / OTC Pink Market: OBSVF), a biopharmaceutical company developing and commercializing novel therapies to improve women’s health, today published its U.S. Annual Report on Form 10-K for Fiscal Year 2022, including the U.S. GAAP financial results for year-end 2022. The U.S. Annual Report on Form 10-K can be accessed in the financial section of the Company’s website, here or directly via the link here.

ObsEva expects to publish its Swiss Annual Report to Shareholders, including the financial results for year end 2022 in IFRS, in the week commencing April 24, 2023.

About ObsEva
ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program focused on improving in vitro fertilization success rates. ObsEva is listed on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN” and on the OTC Pink Market under the ticker symbol “OBSVF”. For more information, please visit www.ObsEva.com

For further information, please contact:

CEO Office contact
Shauna Dillon
shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Will Brown
will.brown@obseva.com
+1 (334) 313-2319

###

 

 

Attachment

• ObsEva - Press Release - YE22 earnings

FAQ

What key financial information did ObsEva release on March 31, 2023?

ObsEva released its U.S. Annual Report on Form 10-K for fiscal year 2022, including key financial results.

When will ObsEva publish its Swiss Annual Report?

ObsEva plans to publish its Swiss Annual Report to Shareholders in the week beginning April 24, 2023.

Where can I find ObsEva's financial statements?

ObsEva's U.S. Annual Report on Form 10-K can be found in the financial section of the company's website.

What is ObsEva's focus as a biopharmaceutical company?

ObsEva develops novel therapies aimed at improving women's reproductive health and pregnancy.

What are the ticker symbols for ObsEva?

ObsEva is traded on the SIX Swiss Exchange under the ticker OBSN and on the OTC Pink Market as OBSVF.